Back to Search
Start Over
miRNA Signature in Early-stage Mycosis Fungoides.
- Source :
- Acta Dermato-Venereologica; 2022, Vol. 102, p1-8, 8p
- Publication Year :
- 2022
-
Abstract
- Altered miRNA expressions are assigned pathogenic properties in several cancers including mycosis fungoides and could play a role in the early onset of the disease. The aim of this study was to examine disease-specific miRNA expression in early-stage mycosis fungoides patch and plaque lesions. A quantitative real-time PCR platform of 384 human miRNAs was used to study miRNA expression in 154 diagnostic mycosis fungoides biopsies. A total of 110 miRNAs were significantly differentially expressed (>2-fold, p < 0.05) between plaque lesions and healthy controls, and 90 miRNAs (>2-fold, p < 0.05) differed between patch lesions and healthy controls. Moreover, 13 miRNAs differed in expression between patch and plaque lesions. Early-stage mycosis fungoides exhibited miRNA features that overlapped with those of psoriasis. However, 39 miRNAs, including miR-142-3p, miR-150 and miR-146b, were specific to mycosis fungoides. In conclusion, early-stage mycosis fungoides expresses a distinct miRNA profile, indicating that miRNAs could play a role in the early development of mycosis fungoides. [ABSTRACT FROM AUTHOR]
- Subjects :
- MYCOSIS fungoides
GENE expression
MICRORNA
CUTANEOUS T-cell lymphoma
Subjects
Details
- Language :
- English
- ISSN :
- 00015555
- Volume :
- 102
- Database :
- Complementary Index
- Journal :
- Acta Dermato-Venereologica
- Publication Type :
- Academic Journal
- Accession number :
- 161258997
- Full Text :
- https://doi.org/10.2340/actadv.v102.628